Small cell lung cancer

Quaratusugene Ozeplasmid Plasmid Plus Atezolizumab in ES-SCLC Receives FTD from FDA | Pharmtales

Quaratusugene Ozeplasmid Plasmid Plus Atezolizumab in ES-SCLC Receives FTD from FDA

SG Tylor

Source – Genprex On June 28, 2023, Genprex has announced that the FDA has granted fast track designation (FTD) to ...